<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365493">
  <stage>Registered</stage>
  <submitdate>17/12/2013</submitdate>
  <approvaldate>20/01/2014</approvaldate>
  <actrnumber>ACTRN12614000058673</actrnumber>
  <trial_identification>
    <studytitle>Comparative Study Between Three Methods of Stem Cell Separation From Umbilical Cord Blood</studytitle>
    <scientifictitle>A study comparing the effectiveness of the density gradient separation using ficoll hypaque, automated processing and harvesting system using AXP Autoxpress- Thermogenesis and magnetic bead separation system using MACS Columns and MACS Separators methods for stem cell separation from umbilical cord blood</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Stem Cells</healthcondition>
    <healthcondition>Stem cell separation from umbilical cord blood</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This study will be carried out on 30 samples of umbilical cord blood. Each sample of cord blood will be collected from the placenta using a special collection bag containing anticoagulant (citrate phosphate dextrose adinine).

	The samples will be divided into three groups:

1.	10 samples of the cord blood from which stem cells will be separated by density gradient separation using ficoll hypaque. This method is performed by centrifugation of a suspension of the cord blood mixed with ficoll-paque followed by isolation of mononuclear cells.

2.	10 samples of the cord blood from which stem cells will be separated by automated processing and harvesting system using AXP autoexpress - Thermogenesis. Cord blood is transferred into the processing bagset which is placed in the AXP device and then centrifuged.  During centrifugation, component stratification and separation occurs.

3.	10 samples of the cord blood from which stem cells will be separated by magnetic bead separation system using MACS Columns and MACS Separators. That depends on labeling CD34+ cells with CD34 microbeads then, the cell suspension is loaded onto a MACS Column which is placed in the magnetic field of a MACS Separator. After removing the column from the magnetic field, the magnetically retained CD34+ cells can be eluted as the positively selected cell fraction.</interventions>
    <comparator>Data from the 30 samples will be plotted to compare the three stem cell separation methods from umbilical cord blood to each other.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>After sample stem cell separation, it will be followed by calculation of the harvested stem cells to define the stem cell separation method with the best outcome of highest stem cell count.</outcome>
      <timepoint>The primary outcome (stem cell count) is assessed in the same day of sample collection from the umbilical cord and stem cell separation from it using each method separately.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>None</outcome>
      <timepoint>None</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Mothers must have consented for cord blood collection at delivery
2. cord blood must be available for extraction of stem cells.
3. &gt;30 weeks gestation
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1. Mothers who would not consent to participate in the study.
2. Chromosomal Abnormalities.
3. Congenital Anomalies.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Alexandria</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Faculty of Medicine - Alexandria University</primarysponsorname>
    <primarysponsoraddress>Alexandria Faculty of Medicine, Champollion St.
Azarita Postcode: 21131
Alexandria
Egypt </primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of the work is to compare three different methods of stem cell separation from umbilical cord blood to define the stem cell separation method with the highest outcome of stem cell count</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alexandria Faculty of Medicine Ethical Committee</ethicname>
      <ethicaddress> Alexandria Faculty of Medicine, Champollion St.
Azarita PO box: 21131
Alexandria
</ethicaddress>
      <ethicapprovaldate>1/12/2013</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Yasser Ibrahim Orief</name>
      <address>Dr. Yasser Orief, El Mosheer Ahmed Ismail St., Panorama El shark Building Sidi gaber Elsheikh tram station above HSBC bank. Postcode: 21615
Alexandria, Egypt

Affiliation: Assistant Professor of Obstetrics and Gynecology - Faculty of Medicine - Alexandria University</address>
      <phone>+20 100 8233 121</phone>
      <fax>+20 3 544 22 64 (extension 102)</fax>
      <email>yaserorief@yahoo.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Yasser Ibrahim Orief</name>
      <address>Dr. Yasser Orief, El Mosheer Ahmed Ismail St., Panorama El shark Building Sidi gaber Elsheikh tram station above HSBC bank. Postcode box: 21615
Alexandria, Egypt

Affiliation: Assistant Professor of Obstetrics and Gynecology - Faculty of Medicine - Alexandria University</address>
      <phone>+20 100 8233 121</phone>
      <fax>+20 3 544 22 64 (extension 102)</fax>
      <email>yaserorief@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Yasser Ibrahim Orief</name>
      <address>Dr. Yasser Orief, El Mosheer Ahmed Ismail St., Panorama El shark Building Sidi gaber Elsheikh tram station above HSBC bank. Postcode box: 21615
Alexandria, Egypt

Affiliation: Assistant Professor of Obstetrics and Gynecology - Faculty of Medicine - Alexandria University</address>
      <phone>+20 100 8233 121</phone>
      <fax>+20 3 544 22 64 (extension 102)</fax>
      <email>yaserorief@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Yasser Ibrahim Orief</name>
      <address>Dr. Yasser Orief, El Mosheer Ahmed Ismail St., Panorama El shark Building Sidi gaber Elsheikh tram station above HSBC bank. Postcode box: 21615
Alexandria, Egypt

Affiliation: Assistant Professor of Obstetrics and Gynecology - Faculty of Medicine - Alexandria University</address>
      <phone>+20 100 8233 121</phone>
      <fax>+20 3 544 22 64 (extension 102)</fax>
      <email>yaserorief@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>